Literature DB >> 11327865

Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.

D Neidhart1, Y Wei, C Cassidy, J Lin, W W Cleland, P A Frey.   

Abstract

The structures of the hemiketal adducts of Ser 195 in chymotrypsin with N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone (AcLF-CF3) and N-acetyl-L-phenylalanyl trifluoromethyl ketone (AcF-CF3) were determined to 1.4-1.5 A by X-ray crystallography. The structures confirm those previously reported at 1.8-2.1 A [Brady, K., Wei, A., Ringe, D., and Abeles, R. H. (1990) Biochemistry 29, 7600-7607]. The 2.6 A spacings between Ndelta1 of His 57 and Odelta1 of Asp 102 are confirmed at 1.3 A resolution, consistent with the low-barrier hydrogen bonds (LBHBs) between His 57 and Asp 102 postulated on the basis of spectroscopy and deuterium isotope effects. The X-ray crystal structure of the hemiacetal adduct between Ser 195 of chymotrypsin and N-acetyl-L-leucyl-L-phenylalanal (AcLF-CHO) has also been determined at pH 7.0. The structure is similar to the AcLF-CF3 adduct, except for the presence of two epimeric adducts in the R- and S-configurations at the hemiacetal carbons. In the (R)-hemiacetal, oxygen is hydrogen bonded to His 57, not the oxyanion site. On the basis of the downfield 1H NMR spectrum in solution, His 57 is not protonated at Nepsilon2, and there is no LBHB at pH >7.0. Because addition of AcLF-CHO to chymotrypsin neither releases nor takes up a proton from solution, it is concluded that the hemiacetal oxygen of the chymotrypsin-AcLF-CHO complex is a hydroxyl group and not attracted to the oxyanion site. The protonation states of the hemiacetal and His 57 are explained by the high basicity of the hemiacetal oxygen (pK(a) > 13.5) relative to that of His 57. The 13C NMR signal for the adduct of AcLF-13CHO with chymotrypsin is consistent with a neutral hemiacetal between pH 7 and 13. At pH <7.0, His 57 in the AcLF-CHO-hemiacetal complex of chymotrypsin undergoes protonation at Nepsilon2 of His 57, leading to a transition of the 15.1 ppm downfield signal to 17.8 ppm. The pK(a)s in the active sites of the AcLF-CF3 and AcLF-CHO adducts suggest an energy barrier of 6-7 kcal x mol(-1) against ionizations that change the electrostatic charge at the active site. However, ionizations of neutral His 57 in the AcLF-CHO-chymotrypsin adduct, or in free chymotrypsin, proceed with no apparent barrier. Protonation of His 57 is accompanied by LBHB formation, suggesting that stabilization by the LBHB overcomes the barrier to ionization. On the basis of the hydration constant for AcLF-13CHO and its inhibition constant, its K(d) is 16 microM, 8000-fold larger than the comparable value for AcLF-CF3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327865     DOI: 10.1021/bi002535a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Localization of ligand binding site in proteins identified in silico.

Authors:  Michal Brylinski; Marek Kochanczyk; Elzbieta Broniatowska; Irena Roterman
Journal:  J Mol Model       Date:  2007-03-30       Impact factor: 1.810

2.  Conformational dynamics of threonine 195 and the S1 subsite in functional trypsin variants.

Authors:  Trevor Gokey; Teaster T Baird; Anton B Guliaev
Journal:  J Mol Model       Date:  2012-08-08       Impact factor: 1.810

3.  13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor.

Authors:  Aleksandra Djurdjevic-Pahl; Chandralal Hewage; J Paul G Malthouse
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

4.  Direct crystallographic observation of an acyl-enzyme intermediate in the elastase-catalyzed hydrolysis of a peptidyl ester substrate: Exploiting the "glass transition" in protein dynamics.

Authors:  Xiaochun Ding; Bjarne F Rasmussen; Gregory A Petsko; Dagmar Ringe
Journal:  Bioorg Chem       Date:  2006-11-02       Impact factor: 5.275

5.  Tautomerism, acid-base equilibria, and H-bonding of the six histidines in subtilisin BPN' by NMR.

Authors:  Regina M Day; Craig J Thalhauser; James L Sudmeier; Matthew P Vincent; Ekaterina V Torchilin; David G Sanford; Christopher W Bachovchin; William W Bachovchin
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

6.  Molecular insights into substrate specificity of prostate specific antigen through structural modeling.

Authors:  Pratap Singh; Aaron M LeBeau; Hans Lilja; Samuel R Denmeade; John T Isaacs
Journal:  Proteins       Date:  2009-12

7.  Structure of a serine protease poised to resynthesize a peptide bond.

Authors:  Elena Zakharova; Martin P Horvath; David P Goldenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-19       Impact factor: 11.205

8.  Proton bridging in the interactions of thrombin with hirudin and its mimics.

Authors:  Ildiko M Kovach; Lazaros Kakalis; Frank Jordan; Daoning Zhang
Journal:  Biochemistry       Date:  2013-04-01       Impact factor: 3.162

9.  Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.

Authors:  David B Berkowitz; Kannan R Karukurichi; Roberto de la Salud-Bea; David L Nelson; Christopher D McCune
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

Review 10.  Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.

Authors:  Ildiko M Kovach
Journal:  Life (Basel)       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.